Design and synthesis of a novel magnetic resonance imaging contrast agent for selective sensing of zinc ion

Chemistry and Biology

Volumn 9, Issue 9, 2002, Pages 1027-1032

  Hanaoka, Kenjiro ^a   Kikuchi, Kazuya ^a,d   Urano, Yasuteru ^a   Narazaki, Michiko ^b   Yokawa, Takashi ^b   Sakamoto, Shigeru ^c   Yamaguchi, Kentaro ^c   Nagano, Tetsuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Drug Discovery Institute   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; CHELATING AGENT; CONTRAST MEDIUM; GADOLINIUM PENTETATE; PROTON; ZINC;

ARTICLE; CHEMICAL MODEL; CHEMISTRY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; SOLUTION AND SOLUBILITY; ULTRAVIOLET SPECTROPHOTOMETRY;

CATIONS; CHELATING AGENTS; CONTRAST MEDIA; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MODELS, CHEMICAL; PROTONS; SENSITIVITY AND SPECIFICITY; SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET; ZINC;

EID: 0036752687     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(02)00216-8     Document Type: Article

References (27)

1. Vallee B.L., Falchuk K.H. The biochemical basis of zinc physiology. Physiol. Rev. 73:1993;79-118.
2. Berg J.M., Shi Y.G. The galvanization of biology. A growing appreciation for the roles of zinc Science. 271:1996;1081-1085.
3. Frederickson C.J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31:1989;145-238.
4. Parker M.M., Humoller F.L., Mahler D.J. Determination of copper and zinc in biological material. Clin. Chem. 13:1967;40-48.
5. Choi D.W., Koh J.Y. Zinc and brain injury. Annu. Rev. Neurosci. 21:1998;347-375.
6. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents. Structure, dynamics, and applications Chem. Rev. 99:1999;2293-2352.
7. Degani H., Gusis V., Weinstein D., Fields S., Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat. Med. 3:1997;780-782.
8. Botta M. Second coordination sphere water molecules and relaxivity of gadolinium(III) complexes. Implications for MRI contrast agents Eur. J. Inorg. Chem. 2000:2000;399-407.
9. Schmitt-Willich H., Brehm M., Ewers C.L.J., Michl G., Müller-Fahrnow A., Petrov O., Platzek J., Radüchel B., Sülzle D. Synthesis and physicochemical characterization of a new gadolinium chelate. The liver-specific magnetic resonance imaging contrast agent Gd-EOB-DTPA Inorg. Chem. 38:1999;1134-1144.
10. Gehl H.B., Bourne M., Grazioli L., Möller A., Lodemann K.P. Off-site evaluation of liver lesion detection by Gd-BOPTA-enhanced MR imaging. Eur. Radiol. 11:2001;187-192.
11. Moats R.A., Fraser S.E., Meade T.J. A "smart" magnetic resonance imaging agent that reports on specific enzymatic activity. Angew. Chem. Int. Ed. Engl. 36:1997;726-728.
12. Louie A.Y., Hüber M.M., Ahrens E.T., Rothbächer U., Moats R., Jacobs R.E., Fraser S.E., Meade T.J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotech. 18:2000;321-325.
13. Li W.H., Fraser S.E., Meade T.J. A calcium-sensitive magnetic resonance imaging contrast agent. J. Am. Chem. Soc. 121:1999;1413-1414.
14. Zhang S.R., Wu K.C., Sherry A.D. A novel pH-sensitive MRI contrast agent. Angew. Chem. Int. Ed. 38:1999;3192-3194.
15. 3+-loaded polyion complex for pH depiction with magnetic resonance imaging. J. Biomed. Mater. Res. 49:2000;390-395.
16. Hirano T., Kikuchi K., Urano Y., Higuchi T., Nagano T. Highly zinc-selective fluorescent sensor molecules suitable for biological applications. J. Am. Chem. Soc. 122:2000;12399-12400.
17. Cuajungco M.P., Lees G.J. Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus. Brain Res. 799:1998;97-107.
18. Hanaoka K., Kikuchi K., Urano Y., Nagano T. Selective sensing of zinc ions with a novel magnetic resonance imaging contrast agent. J. Chem. Soc.-Perkin Trans. 2:2001;1840-1843.
19. Bligh S.W.A., Chowdhury A.H.M.S., Kennedy D., Luchinat C., Parigi G. Non-ionic bulky Gd(III) DTPA-bisamide complexes as potential contrast agents for magnetic resonance imaging. Magn. Reson. Med. 41:1999;767-773.
20. Sakamoto S., Fujita M., Kim K., Yamaguchi K. Characterization of self-assembling nano-sized structures by means of coldspray ionization mass spectrometry. Tetrahedron. 56:2000;955-964.
21. Sakamoto S., Yoshizawa M., Kusukawa T., Fujita M., Yamaguchi K. Characterization of encapsulating supramolecules by using CSI-MS with ionization-promoting reagents. Org. Lett. 3:2001;1601-1604.
22. Yamanoi Y., Sakamoto Y., Kusukawa T., Fujita M., Sakamoto S., Yamaguchi K. Dynamic assembly of coordination boxes from (en)Pd(II) unit and a rectangular panel-like ligand. NMR, CSI-MS, and X-ray studies J. Am. Chem. Soc. 123:2001;980-981.
23. Sillén L.G., Martell A.E. Stability Constants of Metal-ion Complexes, Special Publication No. 17. 1964;The Chemical Society, Burlington House, London.
24. Aime S., Barge A., Botta M., Howard J.A.K., Kataky R., Lowe M.P., Moloney J.M., Parker D., de Sousa A.S. Dependence of the relaxivity and luminescence of gadolinium and europium amino-acid complexes on hydrogencarbonate and pH. Chem. Commun. 11:1999;1047-1048.
25. Lowe M.P., Parker D. Controllable pH modulation of lanthanide luminescence by intramolecular switching of the hydration state. Chem. Commun. 8:2000;707-708.
26. Hardcastle K.I., Botta M., Fasano M., Digilio G. Experimental evidence for a second coordination sphere water molecule in the hydration structure of YbDTPA - Insights for a re-assessment of the relaxivity data of GdDTPA. Eur. J. Inorg. Chem. 5:2000;971-977.
27. Anelli P.L., Bertini I., Fragai M., Lattuada L., Luchinat C., Parigi G. Sulfonamide-functionalized gadolinium DTPA complexes as possible contrast agents for MRI. A relaxometric investigation Eur. J. Inorg. Chem. 4:2000;625-630.